Analysis of the efficacy of lenalidomide in patients with intermediate1 risk myelodysplastic syndrome without 5q deletion

By            

Experimental and Therapeutic Medicine, Vol. 6, Iss. 3, 2013-01 ,pp. : 803-807

Spandidos Publications

Access to resources Recommend Favorite

Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan

By Zuniga R.   Torcuator R.   Jain R.   Anderson J.   Doyle T.   Ellika S.   Schultz L.   Mikkelsen T.  

Journal of Neuro-Oncology, Vol. 91, Iss. 3, 2009-02 ,pp. : 329-336

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer

By Osako Tomo   Ito Yoshinori   Takahashi Shunji   Tokudome Nahomi   Iwase Takuji   Hatake Kiyohiko  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 159-164

Springer Publishing Company

Access to resources Recommend Favorite

Comparative analysis of the efficacy and safety of chemotherapy with oxaliplatin plus fluorouracil/leucovorin between elderly patients over 65 years and younger patients with advanced gastric cancer

By Cho Yo   Kim Sung   Hong Lee M.   Yoo Moon-Won   Bang Ho-Yoon   Lee Kyung-Yung   Yoon So  

Gastric Cancer, Vol. 15, Iss. 4, 2012-10 ,pp. : 389-395

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer

By Degirmenci M.   Karaca B.   Gorumlu G.   Durusoy R.   Demir Piskin G.   Bozkurt M.   Cirak Y.   Tunali D.   Karabulut B.   Sanli U.   Uslu R.  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 585-591

Humana Press, Inc

Access to resources Recommend Favorite